What is it about?
FGF21 behaves as an acute phase reactant and may be used, in the future, as an early marker of neonatal sepsis; however, prior to its clinical use, this protein should undergo rigorous validation in larger studies
Featured Image
Read the Original
This page is a summary of: Association of fibroblast growth factor 21 plasma levels with neonatal sepsis: preliminary results, Clinical Chemistry and Laboratory Medicine (CCLM), September 2018, De Gruyter,
DOI: 10.1515/cclm-2018-0914.
You can read the full text:
Contributors
The following have contributed to this page
